On June 7, 2022, Healthcare Outcomes Performance Company (HOPCo), a U.S. leader in musculoskeletal (MSK) physician practice management, outcomes management, and value-based care solutions, announced the acquisition of MSK-specific technology platforms developed by London-based Future Health Works (FHW), including msk.ai. This partnership will streamline the rollout of evidence-based protocols, automated clinical decision support, remote care management, and value-based care programs.
FHW's innovative software has unique capabilities that include remote patient monitoring (RPM) with real-time patient feedback, artificial intelligence, computer vision, and patented motion capture technology. These platforms, such as myrecovery, have been the preferred patient engagement program for organizations across the UK, including leading hospitals and Integrated Care Systems (ICSs) within the NHS (National Health Service), provider groups, and implant manufacturers, to provide insights into MSK care, drive improved clinical outcomes, and elevate patient experience and engagement.
Wilson Sonsini advised Future Health Works on patent matters related to the transaction. The team included Ellie Han and Lou Lieto.
For more information, please see HOPCo's press release.